Global conference on Group B Strep: Accelerating evidence-based action, for every family, everywhere
When?
Wed 3 – Fri 5 Nov
Where?
All welcome online.
In-person for some at BMA House.
ISSAD2021: Bringing the world together to tackle Group-B Strep
Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date most focus has been on infections in children, yet there are many additional consequences for women themselves, including a huge burden of stillbirths, preterm birth and long-term impacts for affected survivors.
The second International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD2021) will convene stakeholders sharing the latest science to accelerate progress against Group B Strep (GBS), including meningitis.
Wed 3 Nov PM
High profile global launch of WHO’s first ever case value proposition for Group B Strep. The afternoon will be co-hosted with Meningitis Research Foundation, in support of WHO’s defeating meningitis roadmap.
A culmination of years of work by many teams from all over the world, this report presents new data and;
- Analysis regarding long-term health and economic consequences of GBS disease
- Estimated costs/benefits of vaccination or other prevention approaches
The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030.
Thurs 4 Nov all-day
ISSAD Plenary and parallel sessions with the exciting ‘Young ISSAD’ track.
Fri 5 Nov AM
Parallel session and closing plenary
We’ll take you on a journey through three D’s via dynamic and diverse plenaries, plus interactive parallel sessions, a poster competition, scholarships and mentoring for next generation scientists.
- Discovery - genomics and host response to GBS
- Development - including forefront research and new frontiers for vaccines
- Delivery - how do we implement interventions for GBS throughout maternal, newborn and child health (MNCH) systems worldwide
Join us to advance evidence for action against GBS, to protect every family everywhere.
Admission
Contact
